Skip to content

Analysis of Traditional Chinese Medicine Constitution and Related Factors in Children with Adenoid Hypertrophy in the Guangdong Region

Analysis of Traditional Chinese Medicine Constitution and Related Factors in Children with Adenoid Hypertrophy in the Guangdong Region

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123598
Enrollment
Unknown
Registered
2026-04-28
Start date
2024-12-09
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoid hypertrophy

Interventions

Case group:none
Control Group:none

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: Case group 1.Meet the diagnostic criteria for adenoid hypertrophy in the 2024 "Clinical Practice Guidelines for Traditional Chinese Medicine in Children with Adenoid Hypertrophy"; 2.Aged 3 to 10 years; any gender; have lived in Guangdong for =1 year; 3.Illness duration =1 month, with no history of upper or lower respiratory tract infection in the past month; 4.The child and their parents provide informed consent, can understand the questionnaire content, and cooperate with the survey; Control Group 1. Meets the diagnostic criteria for adenoid hypertrophy according to the 2024 "Clinical Practice Guidelines for Chinese Medicine in Pediatric Adenoid Hypertrophy". 2. Age 3 to 10 years; any gender; living in Guangdong for =1 year. 3. Disease course =1 month, with no history of upper or lower respiratory tract infection in the past month. 4. Children and their parents provide informed consent, can understand the questionnaire content, and cooperate with the survey.

Exclusion criteria

Exclusion criteria: Case group 1.History of adenoidectomy or tonsillectomy; 2.Severe sleep disturbances or significant anatomical changes, such as nasal septum deviation; 3.Presence of serious primary diseases affecting the cardiovascular, liver, kidney, hematopoietic, immune systems, or mental disorders; 4.Lack of cooperation from the child or guardian; Control Group 1. Patients who visit the doctor mainly because of ‘snoring during sleep, mouth breathing,’ etc.; 2. Those with a history of AH who have recovered after treatment; 3. Patients with severe primary diseases of the cardiovascular, liver, kidney, hematopoietic, immune systems, or psychiatric disorders; 4. Children or guardians who are uncooperative.

Design outcomes

Primary

MeasureTime frame
Medical history;Traditional Chinese Medicine Constitution;

Countries

China

Contacts

Public ContactLiaoRuosha

Guangdong Provincial Hospital of Chinese Medicine

chindhd2002444@sina.com+86 20 8188 7233

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026